Cancer treatment by comprehensive regulation of anti-tumor immune network

Yutaka Kawakami

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Anti-tumor effects of current cancer vaccines are limited. However, detailed analyses of clinical trials revealed several important points to be improved towards immunological tumor rejection. These are, (1) identification of tumor antigens involved in tumor cell proliferation/survival and expressed in cancer stem cells, (2) development of in situ tumor destruction methods which release tumor antigens in an immunogenic manner to induce immune responses to multiple endogenous tumor antigens, (3) development of methods to augment antigen processing and presentation by dendritic cells, including effective adjuvants, (4) development of methods to expand CTL and helper T cells in vivo, (5) understanding of mechanisms underlying cancer induced immunosuppression and development of methods to overcome them. Comprehensive interventions on these points in the antitumor immune network will lead to effective cancer immunotherapy.

Original languageEnglish
Pages (from-to)1094-1099
Number of pages6
JournalNippon rinsho. Japanese journal of clinical medicine
Volume68
Issue number6
Publication statusPublished - 2010 Jun

Fingerprint

Neoplasm Antigens
Neoplasms
Antigen Presentation
Therapeutics
Cancer Vaccines
Neoplastic Stem Cells
Helper-Inducer T-Lymphocytes
Immunotherapy
Immunosuppression
Dendritic Cells
Cell Survival
Cell Proliferation
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cancer treatment by comprehensive regulation of anti-tumor immune network. / Kawakami, Yutaka.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 68, No. 6, 06.2010, p. 1094-1099.

Research output: Contribution to journalArticle

@article{a6e6dd688ba2416c8776259559432326,
title = "Cancer treatment by comprehensive regulation of anti-tumor immune network",
abstract = "Anti-tumor effects of current cancer vaccines are limited. However, detailed analyses of clinical trials revealed several important points to be improved towards immunological tumor rejection. These are, (1) identification of tumor antigens involved in tumor cell proliferation/survival and expressed in cancer stem cells, (2) development of in situ tumor destruction methods which release tumor antigens in an immunogenic manner to induce immune responses to multiple endogenous tumor antigens, (3) development of methods to augment antigen processing and presentation by dendritic cells, including effective adjuvants, (4) development of methods to expand CTL and helper T cells in vivo, (5) understanding of mechanisms underlying cancer induced immunosuppression and development of methods to overcome them. Comprehensive interventions on these points in the antitumor immune network will lead to effective cancer immunotherapy.",
author = "Yutaka Kawakami",
year = "2010",
month = "6",
language = "English",
volume = "68",
pages = "1094--1099",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "6",

}

TY - JOUR

T1 - Cancer treatment by comprehensive regulation of anti-tumor immune network

AU - Kawakami, Yutaka

PY - 2010/6

Y1 - 2010/6

N2 - Anti-tumor effects of current cancer vaccines are limited. However, detailed analyses of clinical trials revealed several important points to be improved towards immunological tumor rejection. These are, (1) identification of tumor antigens involved in tumor cell proliferation/survival and expressed in cancer stem cells, (2) development of in situ tumor destruction methods which release tumor antigens in an immunogenic manner to induce immune responses to multiple endogenous tumor antigens, (3) development of methods to augment antigen processing and presentation by dendritic cells, including effective adjuvants, (4) development of methods to expand CTL and helper T cells in vivo, (5) understanding of mechanisms underlying cancer induced immunosuppression and development of methods to overcome them. Comprehensive interventions on these points in the antitumor immune network will lead to effective cancer immunotherapy.

AB - Anti-tumor effects of current cancer vaccines are limited. However, detailed analyses of clinical trials revealed several important points to be improved towards immunological tumor rejection. These are, (1) identification of tumor antigens involved in tumor cell proliferation/survival and expressed in cancer stem cells, (2) development of in situ tumor destruction methods which release tumor antigens in an immunogenic manner to induce immune responses to multiple endogenous tumor antigens, (3) development of methods to augment antigen processing and presentation by dendritic cells, including effective adjuvants, (4) development of methods to expand CTL and helper T cells in vivo, (5) understanding of mechanisms underlying cancer induced immunosuppression and development of methods to overcome them. Comprehensive interventions on these points in the antitumor immune network will lead to effective cancer immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=77955909191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955909191&partnerID=8YFLogxK

M3 - Article

C2 - 20535961

AN - SCOPUS:77955909191

VL - 68

SP - 1094

EP - 1099

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 6

ER -